Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma. (Q51012672)
Jump to navigation
Jump to search
scientific article published on 9 December 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma. |
scientific article published on 9 December 2003 |
Statements
1 reference
Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma. (English)
1 reference
1 reference
Hancock BW
1 reference
Wheatley K
1 reference
Harris S
1 reference
Ives N
1 reference
Harrison G
1 reference
Horsman JM
1 reference
Middleton MR
1 reference
Thatcher N
1 reference
Marsden JR
1 reference
Burrows L
1 reference
Gore M
1 reference
9 December 2003
1 reference
22
1 reference
1
1 reference
53-61
1 reference
Identifiers
1 reference